Results 191 to 200 of about 9,029,710 (297)

In vivo and in vitro models of demyelinating diseases

, 1985
Marion B. Coulter-Mackie, Richard R. Adler, Greame A. R. Wilson, Samuel Dales   +3 more
openalex   +1 more source

Contributions of CD8+ T Cells and Viral Spread to Demyelinating Disease [PDF]

, 2000
Norman W. Marten, Stephen A. Stohlman, Roscoe D. Atkinson, David R. Hinton, John O. Fleming, Cornelia C. Bergmann   +5 more
openalex   +1 more source

Cell therapy in demyelinating diseases [PDF]

, 2004
Claire M Rice, Christopher Halfpenny, Neil Scolding   +2 more
openalex   +2 more sources

Diagnostic testing and treatment in Japanese patients with a diagnosis code for chronic inflammatory demyelinating polyradiculoneuropathy: A claims database analysis

Clinical and Experimental Neuroimmunology, Volume 16, Issue 2, Page 98-107, May 2025.
Abstract Objectives Reports of real‐world data concerning chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are limited in Japan. This study aimed to investigate the diagnostic testing and treatment performed in patients diagnosed with CIDP in Japan. Methods Using a Japanese commercial medical information database, we analyzed diagnostic
Motoi Kuwahara, Susumu Kusunoki, Ataru Igarashi, Satoshi Akiyama, Taku Fukushima, Mamoru Doi   +5 more
wiley   +1 more source

In vivo and in vitro models of demyelinating diseases XXIV. The infectious process in cyclosporin A treated Wistar Lewis rats inoculated with JHM virus

, 1989
Mitchell J. Zimmer, Samuel Dales
openalex   +1 more source

Mapping of a New Locus for Autosomal Recessive Demyelinating Charcot-Marie-Tooth Disease to 19q13.1-13.3 in a Large Consanguineous Lebanese Family: Exclusion of MAG as a Candidate Gene [PDF]

, 2000
Valérie Delague, Corinne Bareil, Sylvie Tuffery‐Giraud, Patrice Bouvagnet, Éliane Chouery, Salam Koussa, Thierry Maisonobe, Jacques Loiselet, André Mégarbané, Mireille Claustres   +9 more
openalex   +1 more source

Real‐world safety and treatment patterns of subcutaneous IgPro20 for chronic inflammatory demyelinating polyneuropathy: Post‐marketing surveillance in Japan

Clinical and Experimental Neuroimmunology, Volume 16, Issue 2, Page 108-117, May 2025.
Abstract Objectives IgPro20, a subcutaneous immunoglobulin replacement therapy, is approved in Japan for chronic inflammatory demyelinating polyneuropathy (CIDP). This post‐marketing surveillance study characterized real‐world treatment patterns and safety profile of injection site reactions associated with IgPro20 treatment in Japanese patients with ...
Naoki Terasaka, Takanori Mizushima, Yuki Niwa, Tetsushi Akasaki, Hideo Usui   +4 more
wiley   +1 more source

JHM Infections in Rats as a Model for Acute and Subacute Demyelinating Disease

, 1981
Helmut Wege, Makoto Koga, H. Wege, Volker ter Meulen   +3 more
openalex   +1 more source

Pre-Emptive Targeting of the Epitope Spreading Cascade with Genetically Modified Regulatory T Cells During Autoimmune Demyelinating Disease [PDF]

, 2001
Ling Yin, Canqing Yu, Andrea E. Edling, Julie A. Kawczak, Peter M. Mathisen, Tania Nanavati, Justin M. Johnson, Vincent K. Tuohy   +7 more
openalex   +1 more source

Effect of time to initiation and dose of methylprednisolone on outcome in multiple sclerosis‐related optic neuritis

Clinical and Experimental Neuroimmunology, EarlyView.
Abstract Objectives It is known that the benefit of intravenous methylprednisolone (IVMP) in multiple sclerosis‐related optic neuritis (MS‐ON) is limited to an accelerated recovery. We aimed to evaluate the impact of time from symptoms onset to IVMP initiation and of IVMP dose on visual recovery among people with MS‐ON.
Hadar Gilad, Josepha Horowitz, Sivan Bloch, Daniel Golan   +3 more
wiley   +1 more source